Workflow
OUTFRONT Media(OUT) - 2025 Q4 - Earnings Call Transcript
2026-02-25 22:32
Financial Data and Key Metrics Changes - Consolidated revenues increased by 4.1%, up from 3.5% in Q3, driven by 16% growth in transit and 1% growth in billboard [10] - Consolidated OIBDA rose by 12% to $174 million, while AFFO increased by 8% to $130 million [10][22] - Billboard revenues grew by 0.5%, but would have increased by 3.7% excluding two exited contracts [11] - Transit revenues surged by 16%, with New York MTA revenues up over 20% [12][13] Business Line Data and Key Metrics Changes - Billboard revenues were impacted by the exit of two large contracts, with static billboard revenues up 1.1% and digital billboard revenues down 0.6% [12] - Digital transit revenues increased by 37% to $73 million, while static transit revenues decreased slightly [12] - Combined digital revenue performance grew about 11%, representing 39% of total revenues [13] Market Data and Key Metrics Changes - Strong demand was noted in financial, legal, and tech sectors, while government, political, retail, and auto sectors were weaker [13] - The enterprise segment grew by 1%, with mid-teens growth in transit offset by a decline in billboard revenues [14] Company Strategy and Development Direction - The company is focused on optimizing sales strategy, modernizing workflows, and generating new demand, particularly in transit [6][9] - Investments in technology include partnerships with AWS and AdQuick to enhance advertising planning and buying processes [9][28] - The company aims to redefine the value of out-of-home advertising and increase its share of U.S. ad spend [27] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in continued revenue growth into 2026, with expectations of high single-digit growth in Q1 [25] - The company anticipates a strong performance from the New York MTA, with potential for revenues to exceed the minimum annual guarantee [67] - Management highlighted the importance of upcoming events like the World Cup as a significant revenue driver [46][67] Other Important Information - The company expects to spend approximately $90 million on CapEx in 2026, primarily for digital development [20] - The board of directors maintained a cash dividend of $0.30 payable on March 31 [23] Q&A Session Summary Question: Is there a structural shift in how large advertisers engage? - Management confirmed that partnerships with AWS and AdQuick are designed to unlock new revenue streams for both enterprise and commercial segments [33][34] Question: What is the visibility on transit for the rest of the year? - Management indicated that while transit books later than billboard, they feel optimistic about the year, particularly with MTA performance [38] Question: How is national advertising trending? - Management noted strong support from enterprise brands and highlighted significant campaigns from various sectors, including entertainment and finance [45][46] Question: What revenue is expected from the New York MTA in 2026? - Management expects MTA revenues to step up by about 3% to approximately $161 million, with potential for strong double-digit growth [69][77]
Agilent Technologies(A) - 2026 Q1 - Earnings Call Transcript
2026-02-25 22:32
Agilent Technologies (NYSE:A) Q1 2026 Earnings call February 25, 2026 04:30 PM ET Company ParticipantsAdam Elinoff - Managing DirectorAngelica Riemann - President, Agilent CrossLab GroupBrandon Couillard - Managing DirectorCasey Woodring - VP of Equity ResearchMichael Ryskin - Managing DirectorPadraig McDonnell - President and CEOPatrick Donnelly - Managing Director in Equity ResearchPuneet Souda - Senior Managing Director, Life Science Tools and DiagnosticsSimon May - President of the Life Sciences and App ...
Hamilton Beach(HBB) - 2025 Q4 - Earnings Call Transcript
2026-02-25 22:32
Hamilton Beach Brands Company (NYSE:HBB) Q4 2025 Earnings call February 25, 2026 04:30 PM ET Company ParticipantsAdam Bradley - Founder, CIO, and CEO of Private EquityBrendon Frey - PartnerSally Cunningham - Senior VP, CFO, and TreasurerScott Tidey - President and CEOConference Call ParticipantsGowshi Sri - Equity AnalystOperatorThank you for standing by. At this time, I would like to welcome everyone to Hamilton Beach Brands' 2025 fourth quarter and full year earnings conference call. All lines have been p ...
Agilent Technologies(A) - 2026 Q1 - Earnings Call Transcript
2026-02-25 22:32
Agilent Technologies (NYSE:A) Q1 2026 Earnings call February 25, 2026 04:30 PM ET Company ParticipantsAdam Elinoff - Managing DirectorAngelica Riemann - President, Agilent CrossLab GroupBrandon Couillard - Managing DirectorCasey Woodring - VP of Equity ResearchMichael Ryskin - Managing DirectorPadraig McDonnell - President and CEOPatrick Donnelly - Managing Director in Equity ResearchPuneet Souda - Senior Managing Director, Life Science Tools and DiagnosticsSimon May - President of the Life Sciences and App ...
ACADIA Pharmaceuticals(ACAD) - 2025 Q4 - Earnings Call Transcript
2026-02-25 22:32
ACADIA Pharmaceuticals (NasdaqGS:ACAD) Q4 2025 Earnings call February 25, 2026 04:30 PM ET Company ParticipantsAl Kildani - Senior Vice President of Investor Relations and Corporate CommunicationsAsh Verma - DirectorCaroline Palavicino-Maggio - VPCatherine Owen Adams - CEODavid Hoang - DirectorElizabeth Thompson - EVP and Head of Research and DevelopmentJason Butler - Managing DirectorJulian Pino - AssociateMarc Goodman - Senior Managing Director in NeuroscienceMark Breidenbach - DirectorMark Schneyer - CFO ...
IMAX(IMAX) - 2025 Q4 - Earnings Call Transcript
2026-02-25 22:32
IMAX (NYSE:IMAX) Q4 2025 Earnings call February 25, 2026 04:30 PM ET Company ParticipantsDrew Crum - Managing DirectorJennifer Horsley - SVP, Investor RelationsNatasha Fernandes - CFORichard Gelfond - CEOConference Call ParticipantsChad Beynon - Managing Director and Senior AnalystDavid Joyce - Senior Equity Research AnalystEric Handler - Managing Director and Senior Research AnalystEric Wold - Senior Equity Research AnalystMichael Hickey - Senior Research AnalystOmar Mejias - Equity AnalystPatrick Scholl - ...
Arcutis Biotherapeutics(ARQT) - 2025 Q4 - Earnings Call Transcript
2026-02-25 22:32
Arcutis Biotherapeutics (NasdaqGS:ARQT) Q4 2025 Earnings call February 25, 2026 04:30 PM ET Company ParticipantsBrian Schoelpkopf - VP of Investor RelationsDouglas Tsao - Managing DirectorFrank Watanabe - President and CEOIkenna Okafor - Biotechnology Equity ResearchLata Vyravan - CFOPatrick Burnett - CMORitch Law - VP in Global Investment ResearchSeamus Fernandez - Senior Managing DirectorSerge Belanger - Managing DirectorTodd Edwards - CCOConference Call ParticipantsJudah Frommer - Executive Director, Sen ...
Urban Outfitters(URBN) - 2026 Q4 - Earnings Call Transcript
2026-02-25 22:32
Urban Outfitters (NasdaqGS:URBN) Q4 2026 Earnings call February 25, 2026 04:30 PM ET Company ParticipantsDana Telsey - CEO and CRODave Hayne - Chief Technology Officer and PresidentFrank Conforti - Co-President and COOJanet Joseph Kloppenburg - PresidentMarni Shapiro - Managing PartnerMelanie Marein-Efron - CFOOona McCullough - Executive Director of Investor RelationsPaul Lejuez - Managing Director and Head of Consumer Discretionary ResearchRichard Hayne - CEO and Chairman of the Board of DirectorsShea Jens ...
Sarepta Therapeutics(SRPT) - 2025 Q4 - Earnings Call Transcript
2026-02-25 22:32
Sarepta Therapeutics (NasdaqGS:SRPT) Q4 2025 Earnings call February 25, 2026 04:30 PM ET Company ParticipantsBrian Abrahams - Managing Director and Co-Head of Biotechnology Equity ResearchDoug Ingram - President and Chief Executive OfficerIan M. Estepan - Director of Investor RelationsLouise Rodino-Klapac - Executive VP, Chief Scientific Officer, and Head of Research and DevelopmentPatrick Moss - Executive VP and Chief Commercial OfficerRyan Wong - Interim CFOTazeen Ahmad - Managing DirectorConference Call ...
PROCEPT BioRobotics (PRCT) - 2025 Q4 - Earnings Call Transcript
2026-02-25 22:32
PROCEPT BioRobotics (NasdaqGM:PRCT) Q4 2025 Earnings call February 25, 2026 04:30 PM ET Company ParticipantsKevin Waters - CFOLarry Wood - CEOMatt Bacso - VP of Investor RelationsStephanie Piazzola - VP of Equity Research and Medical TechnologyConference Call ParticipantsBrandon Vazquez - Research AnalystChris Pasquale - Partner and Senior Analyst of Medical Devices and SuppliesDanielle Antalffy - Senior AnalystJosh Jennings - Managing Director and Senior AnalystMatthew O'Brien - Managing Director and Senio ...